Announcement only states that all patients reached 28 days (from date of treatment) without experiencing dose limiting toxicity.
So no positive status updates (not that we would be expecting them at this stage) on any of the patients unfortunately.
- Forums
- ASX - By Stock
- Ann: Successful Completion of First Patient Cohort Phase 1 Trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Announcement only states that all patients reached 28 days (from...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31122 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 721510 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31122 | 0.005 |
4 | 3112327 | 0.004 |
41 | 27362937 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 721510 | 3 |
0.005 | 18599873 | 22 |
0.006 | 13884684 | 16 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
Last trade - 09.39am 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online